Suppr超能文献

前蛋白转化酶枯草杆菌蛋白酶/kexin 5型基因的遗传变异可调节高密度脂蛋白胆固醇水平。

Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levels.

作者信息

Iatan Iulia, Dastani Zari, Do Ron, Weissglas-Volkov Daphna, Ruel Isabelle, Lee Jenny C, Huertas-Vazquez Adriana, Taskinen Marja-Riitta, Prat Annik, Seidah Nabil G, Pajukanta Päivi, Engert James C, Genest Jacques

机构信息

Department of Biochemistry, Cardiovascular Research Laboratories, Cardiology Division, McGill University Health Centre/Royal Victoria Hospital, Montreal, Quebec, Canada.

出版信息

Circ Cardiovasc Genet. 2009 Oct;2(5):467-75. doi: 10.1161/CIRCGENETICS.109.877811. Epub 2009 Aug 22.

Abstract

BACKGROUND

A low level of plasma high-density lipoprotein cholesterol (HDL-C) is a risk factor for cardiovascular disease. HDL particles are modulated by a variety of lipases, including endothelial lipase, a phospholipase present on vascular endothelial cells. The proprotein convertase subtilisin/kexin type 5 (PCSK5) gene product is known to directly inactivate endothelial lipase and indirectly cleave and activate angiopoetin-like protein 3, a natural inhibitor of endothelial lipase. We therefore investigated the effect of human PCSK5 genetic variants on plasma HDL-C levels.

METHODS AND RESULTS

Haplotypes at the PCSK5 locus were examined in 9 multigenerational families that included 60 individuals with HDL-C <10th percentile. Segregation with low HDL-C in 1 family was found. Sequencing of the PCSK5 gene in 12 probands with HDL-C <5th percentile identified 7 novel variants. Using a 2-stage design, we first genotyped these single-nucleotide polymorphisms (SNPs) along with 163 tagSNPs and 12 additional SNPs (n=182 total) in 457 individuals with documented coronary artery disease. We identified 9 SNPs associated with HDL-C (P<0.05), with the strongest results for rs11144782 and rs11144766 (P=0.002 and P=0.005, respectively). The SNP rs11144782 was also associated with very low-density lipoprotein (P=0.039), triglycerides (P=0.049), and total apolipoprotein levels (P=0.022). In stage 2, we replicated the association of rs11144766 with HDL-C (P=0.014) in an independent sample of Finnish low HDL-C families. In a combined analysis of both stages (n=883), region-wide significance of rs11144766 and low HDL-C was observed (unadjusted P=1.86x10(-4) and Bonferroni-adjusted P=0.031).

CONCLUSIONS

We conclude that variability at the PCSK5 locus influences HDL-C levels, possibly through the inactivation of endothelial lipase activity, and, consequently, atherosclerotic cardiovascular disease risk.

摘要

背景

血浆高密度脂蛋白胆固醇(HDL-C)水平较低是心血管疾病的一个危险因素。HDL颗粒受多种脂肪酶调节,包括血管内皮细胞上存在的一种磷脂酶——内皮脂肪酶。已知前蛋白转化酶枯草杆菌蛋白酶/kexin 5型(PCSK5)基因产物可直接使内皮脂肪酶失活,并间接切割和激活血管生成素样蛋白3,后者是内皮脂肪酶的天然抑制剂。因此,我们研究了人类PCSK5基因变异对血浆HDL-C水平的影响。

方法与结果

在9个多代家庭中检查了PCSK5基因座的单倍型,这些家庭包括60名HDL-C处于第10百分位数以下的个体。在1个家庭中发现与低HDL-C存在分离现象。对12名HDL-C处于第5百分位数以下的先证者的PCSK5基因进行测序,发现了7个新的变异。采用两阶段设计,我们首先在457名有冠状动脉疾病记录的个体中对这些单核苷酸多态性(SNP)以及163个标签SNP和另外12个SNP(共182个)进行基因分型。我们鉴定出9个与HDL-C相关的SNP(P<0.05),其中rs11144782和rs11144766的结果最强(分别为P=0.002和P=0.005)。SNP rs11144782还与极低密度脂蛋白(P=0.039)、甘油三酯(P=0.049)和总载脂蛋白水平(P=0.022)相关。在第二阶段,我们在芬兰低HDL-C家庭的独立样本中重复了rs11144766与HDL-C的关联(P=0.014)。在两个阶段的联合分析(n=883)中,观察到rs11144766与低HDL-C的全区域显著性(未校正P=1.86×10⁻⁴,Bonferroni校正P=0.031)。

结论

我们得出结论,PCSK5基因座的变异性可能通过使内皮脂肪酶活性失活而影响HDL-C水平,进而影响动脉粥样硬化性心血管疾病风险。

相似文献

1
Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levels.
Circ Cardiovasc Genet. 2009 Oct;2(5):467-75. doi: 10.1161/CIRCGENETICS.109.877811. Epub 2009 Aug 22.
2
6
Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1.
Circulation. 2018 Sep 25;138(13):1304-1316. doi: 10.1161/CIRCULATIONAHA.118.034710.
8
Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.
Cardiovasc Diabetol. 2012 Oct 8;11:123. doi: 10.1186/1475-2840-11-123.

引用本文的文献

4
Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.
Front Pharmacol. 2022 Sep 15;13:988561. doi: 10.3389/fphar.2022.988561. eCollection 2022.
6
Molecular evolution of PCSK family: Analysis of natural selection rate and gene loss.
PLoS One. 2021 Oct 28;16(10):e0259085. doi: 10.1371/journal.pone.0259085. eCollection 2021.
7
Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis.
Mol Syst Biol. 2021 Jan;17(1):e9684. doi: 10.15252/msb.20209684.
8
Mouse Models of Human Proprotein Convertase Insufficiency.
Endocr Rev. 2021 May 25;42(3):259-294. doi: 10.1210/endrev/bnaa033.
10
Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
Am J Epidemiol. 2019 Jun 1;188(6):1033-1054. doi: 10.1093/aje/kwz005.

本文引用的文献

1
Effect of ABCA1 mutations on risk for myocardial infarction.
Curr Atheroscler Rep. 2008 Oct;10(5):413-26. doi: 10.1007/s11883-008-0064-5.
2
In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate.
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5750-5. doi: 10.1073/pnas.0709428105. Epub 2008 Mar 31.
3
Polymorphisms associated with cholesterol and risk of cardiovascular events.
N Engl J Med. 2008 Mar 20;358(12):1240-9. doi: 10.1056/NEJMoa0706728.
5
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Am J Hum Genet. 2007 Sep;81(3):559-75. doi: 10.1086/519795. Epub 2007 Jul 25.
6
Hepatic proprotein convertases modulate HDL metabolism.
Cell Metab. 2007 Aug;6(2):129-36. doi: 10.1016/j.cmet.2007.07.009.
7
The proprotein convertases are potential targets in the treatment of dyslipidemia.
J Mol Med (Berl). 2007 Jul;85(7):685-96. doi: 10.1007/s00109-007-0172-7. Epub 2007 Mar 10.
8
Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase.
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):366-72. doi: 10.1161/01.ATV.0000252827.51626.89. Epub 2006 Nov 16.
9
The proprotein convertases and their implication in sterol and/or lipid metabolism.
Biol Chem. 2006 Jul;387(7):871-7. doi: 10.1515/BC.2006.110.
10
Genetics of high-density lipoproteins.
Curr Opin Cardiol. 2006 Jul;21(4):329-35. doi: 10.1097/01.hco.0000231403.94856.cd.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验